Skip to playerSkip to main content
#Medicare #WhiteHouseDeal #ObesityDrugs #DrugPrices #WeightLossTreatment #HealthcareNews #EliLilly #NovoNordisk #GLP1 #USHealthCare #AffordableDrugs #TrumpAdministration
Transcript
00:00Big news on weight loss medications. The White House says it struck deals. Eli Lilly, Novo Nordis,
00:05Cuegovi, Ozempic, ZepBound, and expand some Medicare coverage. Here's the quick explainer.
00:10GLP-1 drugs help control appetite. They help control blood sugar. They've shown meaningful
00:15weight loss for many people, but price has been the wall. It's often $500 a month or more and
00:19sometimes over $1,000. What changes under the deal? Pills. Starting doses of upcoming oral
00:24versions are targeted around $149 a month. Injectables. New TrumpRx.gov portal launches
00:34January 2026. Injectables. Prices drop to about $350 a month at first and a glide path toward
00:42roughly $245 over two years. Medicare. Coverage expands beyond diabetes to certain obesity-related
00:49uses starting mid-2026. Many enrollees could see about $50 co-pays, but not everyone qualifies.
00:56Who qualifies under Medicare? Early guidance says it's limited about 10% of enrollees. Focused on
01:01severe obesity, BCR, BRD, BME, over 35, plus related conditions. Criteria will matter. Why this matters?
01:14Why obesity drives massive health costs. Lower prices and coverage could open access to millions who
01:19couldn't afford these meds. It also signals a shift in U.S. drug policy. Trading lower prices for
01:26broader access. Manufacturers are committing to supply while navigating tighter margins and
01:31regulatory incentives. Caveats and what I'm watching. Approvals for pill versions and exact
01:48labeling. The rollout timeline. TrumpRx in January 2026. Medicare coverage from mid-2020. The real
01:52out-of-pocket costs after insurance, long-term budget impact on Medicare. And whether prices stay
02:01down. Bottom line, this could be a turning point for obesity treatment access in the U.S.
02:08Check your eligibility, talk to your provider, and watch for plan updates. Subscribe for clear
02:14updates on drug costs, health care policy, and access.
Be the first to comment
Add your comment

Recommended